Monoclonal antibodies as anti-infective products: a promising future?

BACKGROUND: The paucity of licensed monoclonal antibodies (mAbs) in the infectious diseases arena strongly contrasts with the ready availability of these therapeutics for use in other conditions. AIMS: This narrative review aims to assess the potential of monoclonal antibody-based interventions for...

Descripción completa

Detalles Bibliográficos
Autores principales: Pelfrene, E., Mura, M., Cavaleiro Sanches, A., Cavaleri, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7128139/
https://www.ncbi.nlm.nih.gov/pubmed/29715552
http://dx.doi.org/10.1016/j.cmi.2018.04.024

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7128139/
https://www.ncbi.nlm.nih.gov/pubmed/29715552
http://dx.doi.org/10.1016/j.cmi.2018.04.024

Ejemplares similares